Spark Investment Management’s Pliant Therapeutics PLRX Stock Holding History

Spark Investment Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.8K	Buy	+22,600	New	+$27.5K	0.05%	67

Other funds holding PLRX

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BDFN

Bond & Devick Financial Network St. Louis Park, Minnesota $406M AUM 16.49% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Spark Investment Management's PLRX Position: Q2 2026 in Review

Spark Investment Management opened a new position in Pliant Therapeutics (PLRX) in Q2 2026: 22,600 shares worth $25.8K. The stake represents 0.05% of the portfolio and ranks #67 among its holdings.

18 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Spark Investment Management held 22,600 shares of Pliant Therapeutics worth $25.8K as of Q2 2026.
Pliant Therapeutics was a new Spark Investment Management position in Q2 2026.
Pliant Therapeutics made up 0.05% of Spark Investment Management's portfolio in Q2 2026, its #67 holding.
18 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Spark Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.